RxDoctor Payments DataLook up a doctor →

Michael Farnsworth, MD

Psychiatry · Mankato, MNNPI 1932183274

Payments from drug & device makers

$547,762in general payments, 2019–2025

Across 624 payments — averaging $877.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$265K
  • Otsuka America Pharmaceutical, Inc.$250K
  • E.r. Squibb & Sons, L.L.C.$28K
  • Sunovion Pharmaceuticals Inc.$4K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • Lundbeck LLC$114
  • plus $133 from 2 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$547,762 in reported general payments places this provider in the 95th percentile of 552 psychiatry providers in Minnesota.

See all psychiatry providers in Minnesota

Medicare billing

Part B allowed, 2024
$16,063
Medicare patients
36
Services billed
144

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other psychiatry in Mankato

See the full list for Minnesota

Where these figures come from

Is this you, or does something look wrong? →